Distribution of insulin in trigeminal nerve and brain after intranasal administration

Jeffrey J. Lochhead, Kathryn L. Kellohen, Patrick T Ronaldson, Thomas P Davis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer’s disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.

Original languageEnglish (US)
Article number2621
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Intranasal Administration
Trigeminal Nerve
Insulin
Brain
Central Nervous System
Alzheimer Disease
Central Nervous System Diseases
Insulin Receptor
Parkinson Disease
Intercellular Signaling Peptides and Proteins
Homeostasis
Clinical Trials
Learning

ASJC Scopus subject areas

  • General

Cite this

Distribution of insulin in trigeminal nerve and brain after intranasal administration. / Lochhead, Jeffrey J.; Kellohen, Kathryn L.; Ronaldson, Patrick T; Davis, Thomas P.

In: Scientific reports, Vol. 9, No. 1, 2621, 01.12.2019.

Research output: Contribution to journalArticle

@article{8a5974a611bd4af4a969a0508f847b5f,
title = "Distribution of insulin in trigeminal nerve and brain after intranasal administration",
abstract = "In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer’s disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.",
author = "Lochhead, {Jeffrey J.} and Kellohen, {Kathryn L.} and Ronaldson, {Patrick T} and Davis, {Thomas P}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-39191-5",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Distribution of insulin in trigeminal nerve and brain after intranasal administration

AU - Lochhead, Jeffrey J.

AU - Kellohen, Kathryn L.

AU - Ronaldson, Patrick T

AU - Davis, Thomas P

PY - 2019/12/1

Y1 - 2019/12/1

N2 - In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer’s disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.

AB - In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer’s disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.

UR - http://www.scopus.com/inward/record.url?scp=85062011658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062011658&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-39191-5

DO - 10.1038/s41598-019-39191-5

M3 - Article

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 2621

ER -